Decheng Capital VC
Investments by market, targeted sectors and preferred funding rounds
Name - Decheng Capital
Description -
healthtech - 50%
biotech - 50%
Decheng Capital invested in
Neurelis during a round worth
$114,000,000 - 3/11/2021 Decheng Capital invested in
Encodia during a round worth
$75,000,000 - 1/28/2021